Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.7M Sell
3,116,809
-55,200
-2% -$984K 0.7% 39
2026
Q1
$60.4M Sell
3,172,009
-148,150
-4% -$2.86M 0.92% 24
2025
Q4
$54.4M Buy
3,320,159
+1,287,282
+63% +$22.7M 0.77% 34
2025
Q3
$38.2M Buy
+2,032,877
New +$36.5M 0.59% 37
2024
Q4
Sell
-510,764
Closed -$9.16M 170
2024
Q3
$9.16M Buy
+510,764
New +$9.31M 0.15% 73
2023
Q1
Sell
-120,289
Closed -$1.85M 321
2022
Q4
$1.85M Hold
120,289
0.02% 279
2022
Q3
$2.29M Sell
120,289
-9,872
-8% -$196K 0.03% 264
2022
Q2
$2.34M Hold
130,161
0.03% 247
2022
Q1
$3.92M Sell
130,161
-31,638
-20% -$987K 0.04% 172
2021
Q4
$4.65M Buy
+161,799
New +$5.27M 0.05% 139

Other funds holding XP

Howard Marks's XP Position: Q2 2026 in Review

Howard Marks reduced its XP (XP) stake by 1.7% in Q2 2026, selling an estimated $984K and leaving 3,116,809 shares worth $50.7M. The position accounts for 0.7% of the portfolio, ranked #39.

Howard Marks first reported a position in XP in Q4 2021 and has held it in 10 quarters since. The position peaked at $60.4M in Q1 2026. 319 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Howard Marks held 3,116,809 shares of XP worth $50.7M as of Q2 2026.
  • Howard Marks sold 55,200 XP shares in Q2 2026, an estimated $984K.
  • XP made up 0.7% of Howard Marks's portfolio in Q2 2026, its #39 holding.
  • Howard Marks first reported a position in XP in Q4 2021 and has held it in 10 quarters since.
  • Howard Marks's XP position peaked at $60.4M in Q1 2026.
  • 319 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Oaktree Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.